BIO 2025 brings pharma, biotech, and policy leaders together to tackle industry challenges. Follow our coverage on AI, vaccines, cell & gene therapy, and key discussions from health officials.

The most successful pharma sales teams will be those that define and service customers in new ways. Those who are the most responsive and relevant to today's customers and influencers will reap ...

Hannah Blake pharmaphorum Threshold Pharma is to go ahead with Phase 3 clinical trials of its only drug, TH-302, despite recent Phase 2 trials failing to show statistically significant improvement ...

BioNTech has agreed to buy another specialist in mRNA-based vaccines and therapeutics, fellow German biotech CureVac, in an all-stock deal valued at around $1.25 billion. Under the terms of the ...

This month, we explore the 125-year-old history of Abbott Laboratories and its most significant milestone to date – the creation of its own independent company, AbbVie.

RFK Jr names eight members of the CDC's vaccine panel, some known for contrarian views on immunisation, after ousting all 17 of their predecessors.

As major pharmacy chains like Walgreens continue to close hundreds of stores nationwide, pharmacy deserts are increasing across the US. These closures put medication access, affordability, and ...

AstraZeneca taps China's CSPC Pharma for new drug candidates a second time – and the latest AI-focused alliance is a big one.

Shionogi has added to its antibiotics pipeline by taking an option on a preclinical-stage candidate from BioVersys for non-tuberculous mycobacteria.

We interview five healthcare professionals to get honest feedback on their views of pharma. First up is a male consultant who specialises in anaesthetics. To coincide with our medical ...

A smartphone app for depression developed by Otsuka and Click Therapeutics has been launched in Great Britain, its first European market ...

Explore the impact of cultural undertow on the transformation of biopharma companies and therapies beyond the vision, delving into the challenges and strategies for success.